| Serial Number | 98210960 |
| Word Mark | SAVYSCUS |
| Filing Date | Thursday, October 5, 2023 |
| Status | 641 - NON-FINAL ACTION - MAILED |
| Status Date | Sunday, November 10, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Custom processing of human cells, for others; custom manufacturing, namely, compounding and processing of chemicals, for others; consultancy relating to custom manufacturing in the nature of formulating and processing of chemicals; custom manufacturing, namely, producing and processing of chemicals and proteins, for others; consultancy relating to custom manufacturing in the nature of producing and processing of chemicals and proteins; providing technical information in the field of chemical manufacturing; custom manufacture of pharmaceuticals by pharmaceutical compounders; custom manufacture of dietary supplements; rental of chemical processing machines; processing of medical materials, namely, custom fabrication and assembly of artificial materials for use in the replacement of bones, cartilage, skin, tissue and muscles |
| Description of Mark | The mark consists of the stylized wording "SAVYSCUS" appearing in teal to the right of two opposing curvilinear shapes appearing in shades of teal. |
| Goods and Services | Pharmaceutical preparations for the treatment of musculo-skeletal disorders, damaged skin and tissue, and for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for treating and preventing knee cartilage and meniscus injuries and disorders, and for knee cartilage and meniscus regeneration; reagent paper for medical purposes; cultured cells intended for subsequent injection and/or implantation in the treatment of cartilage and meniscus injuries; stem cells for medical and veterinary purposes; medical diagnostic pharmaceutical preparations for use in diagnosis of musculo-skeletal, tendon cartilage, and meniscus disorders and injuries; implants comprising living tissue; reagent kits for medical purposes comprising chemical agents, skin, cartilage and other cells; cell growth media for growing cells for medical use; cellular function activating agents for medical purposes; cells for medical use; stem cell preparations for the treatment of muscular dystrophy, musculoskeletal disorders, damaged skin and tissue, and for treating tendon and muscle injuries and disorders, sports related injuries, and for treating knee cartilage and meniscus injuries and disorders, and for knee cartilage and meniscus regeneration; medicinal preparations for musculo-skeletal disorders, damaged skin and tissue, and for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for treating and preventing knee cartilage and meniscus injuries and disorders, and for knee cartilage and meniscus regeneration; medical diagnostic reagents; biochemical preparations for medical purposes, namely, for the diagnosis and treatment of musculo-skeletal disorders, damaged skin and tissue, and for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for treating and preventing knee cartilage and meniscus injuries and disorders, and for knee cartilage and meniscus regeneration; biological tissue cultures for medical purposes, namely, for medical gene cell therapy; biological tissue cultures for medical purposes; oiled paper for medical purposes; adhesive tapes for medical purposes; medical adhesives for binding internal tissue and for binding wounds; culture media for use in augmentation of bone and tissue for medical purposes |
| Indication of Colors claimed | The color(s) teal is/are claimed as a feature of the mark. |
| Goods and Services | Providing on-line medical record analysis services designed to provide patients with custom tailored information about the range of possible diagnoses and therapies associated with a defined set of symptoms; consulting services in the field of medical care; medical diagnostic and therapy services using regenerative medicine; medical therapy services using cultured cells; stem cell therapy services; medical diagnostic and therapy services using genetic information; health counseling; rental of medical equipment; dietary and nutritional guidance; veterinary services; medical services relating to the processing of human cells for the treatment of muscular dystrophy, musculo-skeletal disorders, damaged skin and tissue, and for treating tendon and muscle injuries and disorders, sports related injuries, and for treating knee cartilage and meniscus injuries and disorders, and for knee cartilage and meniscus regeneration; consultancy in the field of transplantation of cultured skin |
| Goods and Services | Medical apparatus and instruments for use in orthopedic surgery and stem cell transplants; apparatus for the regeneration of stem cells for medical purposes; auxiliary medical devices in the nature of orthopedic support apparatus, and orthodontic apparatus comprising headgear, brackets and appliances; cell culture apparatus for medical use, namely, cell culture chambers; surgical apparatus and instruments for veterinary use; osseous implants made of artificial materials; medical implants made of artificial materials |
| Goods and Services | Testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs; research and development services in the field of cytology; medical and scientific research services, namely, custom cell culturing; testing, inspection, research and development of cell and tissue culturing; research and development of medicines; testing the functionality of machines; research on machines; testing the functionality of medical machines; research on medical machines; providing temporary use of on-line nondownloadable computer programs for use in database management and for analysis of medical diagnostic information; cloud computing featuring software for use in storing, analysis and sharing of medical diagnostic information; cloud computing featuring software for use in database management, information management, data collection and data analysis in the medical field; conducting early evaluations in the field of new pharmaceuticals; development of pharmaceutical preparations and medicines; pharmaceutical product evaluation; research and development services in the field of medical preparations; scientific research and development in the field of product development of pharmaceutical preparations and test reagents, and consultancy services relating thereto; scientific research and development; medical research; scientific investigations for medical purposes; computer programming; computer programming and software design; technical advice relating to the operation of computers, automobiles and industrial machines; rental of measuring apparatus; rental of laboratory apparatus and instruments; rental of computers; custom design and development of chemical reagents |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, October 14, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, October 14, 2023 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, October 14, 2023 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, October 14, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, October 14, 2023 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | FUJIFILM Corporation |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Minato-ku, Tokyo 106-8620 JP |
| Event Date | Event Description |
| Monday, October 9, 2023 | NEW APPLICATION ENTERED |
| Saturday, October 14, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, October 17, 2023 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Monday, April 22, 2024 | NON-FINAL ACTION E-MAILED |
| Monday, April 22, 2024 | NON-FINAL ACTION WRITTEN |
| Monday, April 22, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, April 22, 2024 | ASSIGNED TO EXAMINER |
| Tuesday, June 4, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, September 30, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, September 30, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, September 30, 2024 | ASSIGNED TO LIE |
| Saturday, October 26, 2024 | FINAL REFUSAL E-MAILED |
| Saturday, October 26, 2024 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Saturday, October 26, 2024 | FINAL REFUSAL WRITTEN |
| Sunday, November 10, 2024 | NON-FINAL ACTION WRITTEN |
| Sunday, November 10, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Sunday, November 10, 2024 | NON-FINAL ACTION E-MAILED |